{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Vinfosiltine",
  "nciThesaurus": {
    "casRegistry": "123286-00-0",
    "chebiId": "",
    "chemicalFormula": "C51H72N5O10P",
    "definition": "An aminophosphonate derivative of a vinca alkaloid with potential antineoplastic activity. Vinfosiltine exerts its antineoplastic action just like its parent compound, vinblastine, by immobilizing tubulin molecules, thereby interrupting microtubule assembly/disassembly dynamics. As a result, vinfosiltine prevents mitotic spindle formation and leads to cell cycle arrest in metaphase.",
    "fdaUniiCode": "AW1UYE6Q9I",
    "identifier": "C2378",
    "preferredName": "Vinfosiltine",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C67422",
      "C932"
    ],
    "synonyms": [
      "S12363",
      "VINFOSILTINE",
      "Vincaleukoblastine, O4-Deacetyl-3-de(methoxycarbonyl)-3-(((1-(diethoxyphosphinyl)-2-methylpropyl)amin)carbonyl)-,(3(S))-,Sulfate(Salt)",
      "Vinfosiltine"
    ]
  }
}